Intas Pharmaceuticals Ltd
Denosumab
Osteoporosis, multiple myeloma
1 PREFILLED SYRINGE(s) OF 1ML
Injection
Olimab 60mg Injection is a prescription medicine used to treat osteoporosis and help strengthen weak bones. It contains denosumab, a targeted therapy that works by slowing down the breakdown of bone, making it stronger and less likely to fracture. Given as a simple injection under medical supervision, Olimab helps reduce the risk of spine, hip, and other bone fractures, especially in postmenopausal women and people at high risk of bone loss.
Olimab 60mg Injection helps strengthen weak and fragile bones by slowing down the process of bone breakdown. It is mainly used to treat osteoporosis in postmenopausal women and in men at high risk of fractures. By improving bone density over time, Olimab significantly reduces the risk of spine, hip, and other bone fractures, helping patients stay active and independent.
Another key benefit of Olimab is its convenient dosing schedule; it is given as an injection once every six months under medical supervision. With regular treatment and proper calcium and vitamin D support, it helps maintain long-term bone health and supports better mobility and quality of life.
Olimab 60mg Injection is generally well tolerated, but like any medicine, it may cause some side effects. These effects vary from person to person and are usually manageable under medical supervision.
It is important to inform your doctor immediately if you experience severe bone pain, jaw pain, swelling, numbness, or signs of infection. Regular monitoring of calcium levels may be recommended during treatment.
Use only under medical supervision.
May lower calcium levels ensure adequate calcium and vitamin D intake as advised.
Can increase the risk of infections and rare jaw problems; maintain good oral hygiene.
Report any unusual thigh, hip, or jaw pain to your doctor.
Not recommended during pregnancy or breastfeeding.
Store in a refrigerator at 2°C to 8°C.
Do not freeze or shake.
Olimab is used to treat osteoporosis and strengthen weak bones, helping reduce the risk of spine, hip, and other fractures.
It contains denosumab, which slows down bone breakdown and helps improve bone density over time.
Olimab is given as a subcutaneous injection once every 6 months under medical supervision.
Yes, doctors usually recommend calcium and vitamin D supplements to prevent low calcium levels during treatment.
If you miss a scheduled injection, contact your doctor as soon as possible to reschedule. Delaying doses may reduce its effectiveness in protecting your bones.
Olimab 60mg Injection is a prescription medicine used to treat osteoporosis and help strengthen weak bones. It contains denosumab, a targeted therapy that works by slowing down the breakdown of bone, making it stronger and less likely to fracture. Given as a simple injection under medical supervision, Olimab helps reduce the risk of spine, hip, and other bone fractures, especially in postmenopausal women and people at high risk of bone loss.
Olimab 60mg Injection helps strengthen weak and fragile bones by slowing down the process of bone breakdown. It is mainly used to treat osteoporosis in postmenopausal women and in men at high risk of fractures. By improving bone density over time, Olimab significantly reduces the risk of spine, hip, and other bone fractures, helping patients stay active and independent.
Another key benefit of Olimab is its convenient dosing schedule; it is given as an injection once every six months under medical supervision. With regular treatment and proper calcium and vitamin D support, it helps maintain long-term bone health and supports better mobility and quality of life.
Olimab 60mg Injection is generally well tolerated, but like any medicine, it may cause some side effects. These effects vary from person to person and are usually manageable under medical supervision.
It is important to inform your doctor immediately if you experience severe bone pain, jaw pain, swelling, numbness, or signs of infection. Regular monitoring of calcium levels may be recommended during treatment.
Use only under medical supervision.
May lower calcium levels ensure adequate calcium and vitamin D intake as advised.
Can increase the risk of infections and rare jaw problems; maintain good oral hygiene.
Report any unusual thigh, hip, or jaw pain to your doctor.
Not recommended during pregnancy or breastfeeding.
Store in a refrigerator at 2°C to 8°C.
Do not freeze or shake.
Olimab is used to treat osteoporosis and strengthen weak bones, helping reduce the risk of spine, hip, and other fractures.
It contains denosumab, which slows down bone breakdown and helps improve bone density over time.
Olimab is given as a subcutaneous injection once every 6 months under medical supervision.
Yes, doctors usually recommend calcium and vitamin D supplements to prevent low calcium levels during treatment.
If you miss a scheduled injection, contact your doctor as soon as possible to reschedule. Delaying doses may reduce its effectiveness in protecting your bones.
Sourced from Manufacturers
Air Express Delivery
Trusted Medicines
Get Up to 85% Off